Study shows social deprivation a key factor in mortality in type 1 diabetes

September 24, 2013

Levels of social deprivation, as well as how well a patient controls their blood sugar, is an independent risk factor for mortality in people with type 1 diabetes. These are the findings of new research presented at this year's annual meeting of the European Association for the Study of Diabetes in Barcelona, Spain. The research is by the Diabetes Clinical Academic Group at King's Healthcare Partners, UK, and presented by Dr Stephen Thomas, Dept of Diabetes and Endocrinology, Guy's and St Thomas' Hospitals NHS Foundation Trust (GSTT), London.

Despite advances in care in recent decades, with continue to have increased mortality and morbidity. "In order to optimise specialist services with the aim of improving outcomes, this study set out to determine modifiable factors that influence mortality in type 1 ," says Dr Thomas.

The researchers analysed (HbA1c levels), demographics and health resource utilisation data collected over a 10 year period for a cohort of 1038 patients with type 1 diabetes attending two inner city London specialist diabetes outpatient clinics. (GSTT and King's College hospital) All patients attending the service in 2002 with HbA1c data, a measure of blood glucose control, available for each year from 2002 to 2004 and with ongoing follow-up within the clinics until 2010 were included. Economic status was determined using the index of multiple deprivation (IMD) a weighted deprivation score derived from a national dataset based on postcode of residence.

The group had a mean age at baseline of 42 years and had had diabetes for a mean of 18 years . The average baseline HbA1c between 2002 and 2004 was 8.1%. In total, 37 deaths occurred by 2012 (3.6% cumulative mortality). Those who died were on average older with a higher mean baseline HbA1c (9.1%) Having a baseline HbA1c over 9.0% carried a cumulative 10-year morality that was significantly increased at 9%. Those who died were more likely to be socially deprived, with 61% of deceased patients having scores in the poorest 20% of the population range (mean IMD score 32 points deceased vs 24 points for patients still alive). Age, HbA1c and deprivation were all independent risk factors for death of patients with type 1 diabetes.

Dr Thomas concludes: "Glycaemic control and are independent risk factors for in type 1 diabetes and identify areas where we need to target interventions to improve health outcomes."

He adds: "This data analysis is ongoing and offers the possibility of much needed insights into where healthcare outcomes need to be addressed."

Explore further: Patient-centered diabetes care best in those with high HbA1c

Related Stories

Patient-centered diabetes care best in those with high HbA1c

September 18, 2013
(HealthDay)—Patient-centered diabetes care is most effective when targeted to patients with HbA1c >8.5 percent, according to a study published online Aug. 15 in Diabetes Care.

Large European study suggests men with type 1 diabetes are better at blood sugar control than women

September 23, 2013
Men with type 1 diabetes appear to be better at blood sugar control than women, but there is no significant difference in blood sugar control between boys and girls. These are the findings of new research presented at this ...

Most youth with type 1 diabetes don't meet HbA1c goals

February 8, 2013
(HealthDay)—Most children with type 1 diabetes (T1D) have hemoglobin A1c (HbA1c) values above target levels, according to a study published online Jan. 22 in Diabetes Care.

Measures of glucose and its variability are inter-related

September 11, 2013
(HealthDay)—Hemoglobin A1c (HbA1c) and glycated albumin (GA) are inter-related and correlate with retinopathy and nephropathy, while only HbA1c correlates with cardiovascular disease, according to a study published online ...

Lixisenatide non-inferior to exenatide for diabetes

June 7, 2013
(HealthDay)—In adults with type 2 diabetes not adequately controlled with metformin, lixisenatide once daily offers diabetes control similar to that of exenatide twice daily, with some added benefits, according to a study ...

Insulin pumps to treat type 1 diabetes in children control blood sugar more effectively than injections

August 18, 2013
The longest and largest study of the effectiveness of insulin pumps to treat type 1 diabetes in children has shown that the pumps are more effective at controlling blood sugar than insulin injections and cause fewer complications. ...

Recommended for you

Screen time linked to diabetes

July 28, 2017
Daily screen time of three or more hours is linked to several risk factors associated with the development of diabetes in children, according to a study by St George's, University of London.

Diabetes can be tracked with our Google searches

July 26, 2017
The emergence of Type 2 Diabetes could be more effectively monitored using our Google searches—helping public health officials keep track of the disease and halt its spread—according to research by the University of Warwick.

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.